Search research articles
Contact Us
Filters
Showing results (311-320 of 314) with videos related to
Page
of 32
Sort By:
You have reached the last page of results.
This site can display upto 314 results.
Journal of the National Cancer Institute
|
October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.
JAMA
|
April 10, 2019
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database
Gaurav Singal, Peter G Miller, Vineeta Agarwala, et al.
JAMA Oncology
|
August 14, 2015
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou C Dueck, Tito R Mendoza, Sandra A Mitchell, et al.
JAMA Internal Medicine
|
March 24, 2015
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial
Jean S Kutner, Patrick J Blatchford, Donald H Taylor, et al.
Page
of 32
Search research articles
Search
Showing results (311-320 of 314) with videos related to
Sort By:
Page
of 32
You have reached the last page of results.
This site can display upto 314 results.
Journal of the National Cancer Institute
|
October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.
JAMA
|
April 10, 2019
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database
Gaurav Singal, Peter G Miller, Vineeta Agarwala, et al.
JAMA Oncology
|
August 14, 2015
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou C Dueck, Tito R Mendoza, Sandra A Mitchell, et al.
JAMA Internal Medicine
|
March 24, 2015
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial
Jean S Kutner, Patrick J Blatchford, Donald H Taylor, et al.
Page
of 32